How soon should patients be eligible for differentiated service delivery models for antiretroviral treatment? Evidence from Zambia
Lise Jamieson, View ORCID ProfileSydney Rosen, Bevis Phiri, Anna Grimsrud, Muya Mwansa, Hilda Shakwelele, Prudence Haimbe, Mpande M Mwenechanya, Priscilla Lumano-Mulenga, Innocent Chimboma, Brooke E Nichols
doi: https://doi.org/10.1101/2021.08.25.21262587
Lise Jamieson
12, Johannesburg, South Africa
2Department of Medical Microbiology, Amsterdam University Medical Centre, Amsterdam, the Netherlands
Sydney Rosen
12, Johannesburg, South Africa
3Department of Global Health, Boston University School of Public Health, Boston, MA, USA
Bevis Phiri
4Clinton Health Access Initiative, Lusaka, Zambia
Anna Grimsrud
5International AIDS Society, Cape Town, South Africa
Muya Mwansa
6Ministry of Health, Lusaka, Zambia
Hilda Shakwelele
4Clinton Health Access Initiative, Lusaka, Zambia
Prudence Haimbe
4Clinton Health Access Initiative, Lusaka, Zambia
Mpande M Mwenechanya
7The Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
Priscilla Lumano-Mulenga
6Ministry of Health, Lusaka, Zambia
Innocent Chimboma
6Ministry of Health, Lusaka, Zambia
Brooke E Nichols
12, Johannesburg, South Africa
2Department of Medical Microbiology, Amsterdam University Medical Centre, Amsterdam, the Netherlands
3Department of Global Health, Boston University School of Public Health, Boston, MA, USA
Data Availability
Raw data were obtained from Zambia's national electronic medical record system. Derived data supporting the findings of this study are available from the corresponding author [BEN] on request.
Posted March 13, 2022.
How soon should patients be eligible for differentiated service delivery models for antiretroviral treatment? Evidence from Zambia
Lise Jamieson, Sydney Rosen, Bevis Phiri, Anna Grimsrud, Muya Mwansa, Hilda Shakwelele, Prudence Haimbe, Mpande M Mwenechanya, Priscilla Lumano-Mulenga, Innocent Chimboma, Brooke E Nichols
medRxiv 2021.08.25.21262587; doi: https://doi.org/10.1101/2021.08.25.21262587
How soon should patients be eligible for differentiated service delivery models for antiretroviral treatment? Evidence from Zambia
Lise Jamieson, Sydney Rosen, Bevis Phiri, Anna Grimsrud, Muya Mwansa, Hilda Shakwelele, Prudence Haimbe, Mpande M Mwenechanya, Priscilla Lumano-Mulenga, Innocent Chimboma, Brooke E Nichols
medRxiv 2021.08.25.21262587; doi: https://doi.org/10.1101/2021.08.25.21262587
Subject Area
Subject Areas
- Addiction Medicine (395)
- Allergy and Immunology (707)
- Anesthesia (198)
- Cardiovascular Medicine (2905)
- Dermatology (249)
- Emergency Medicine (435)
- Epidemiology (12674)
- Forensic Medicine (10)
- Gastroenterology (822)
- Genetic and Genomic Medicine (4530)
- Geriatric Medicine (411)
- Health Economics (722)
- Health Informatics (2895)
- Health Policy (1065)
- Hematology (382)
- HIV/AIDS (917)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4292)
- Nursing (233)
- Nutrition (630)
- Oncology (2249)
- Ophthalmology (639)
- Orthopedics (257)
- Otolaryngology (324)
- Pain Medicine (274)
- Palliative Medicine (83)
- Pathology (493)
- Pediatrics (1190)
- Primary Care Research (491)
- Public and Global Health (6877)
- Radiology and Imaging (1514)
- Respiratory Medicine (912)
- Rheumatology (433)
- Sports Medicine (381)
- Surgery (481)
- Toxicology (60)
- Transplantation (208)
- Urology (178)